Загрузка...
Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
OBJECTIVE: Sorafenib is an oral multikinase inhibitor that has been proven effective as a single-agent therapy in hepatocellular carcinoma, and there is a strong rationale for investigating its use in combination with other agents. Vitamin K2 is nearly non-toxic to humans and has been shown to inhib...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3438252/ https://ncbi.nlm.nih.gov/pubmed/23018309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2012(09)18 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|